Cargando...

Emerging Pharmacological Treatment in Nonalcoholic Steatohepatitis

BACKGROUND: The increasing prevalence of nonalcoholic ­fatty liver disease has led to a strong demand for an optimal therapeutic approach. At present, guidelines recommend lifestyle changes, but it has become apparent that pharmacotherapy will be required in patients with advanced disease to prevent...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Visc Med
Autor Principal: Schattenberg, Jörn M
Formato: Artigo
Idioma:Inglês
Publicado: S. Karger GmbH 2020
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7672521/
https://ncbi.nlm.nih.gov/pubmed/33251276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000507231
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!